Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saracatinib in extensive stage small cell lung cancer
NCT00528645Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Nov 2007
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of saracatinib in small cell lung cancer (SCLC), sponsored by National Cancer Institute. Started Nov 2007; status: completed.
02
Drugs
saracatinib
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00528645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00528645.